BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3619124)

  • 1. Effects of pentoxifylline and prostaglandin E1 on cold blood perfusion studied by red blood cell deformability.
    Sakai A; Kikuchi Y; Ohshima N; Hori M
    Angiology; 1987 Jul; 38(7):514-9. PubMed ID: 3619124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of pentoxifylline and metabolite on red blood cell deformability as measured by ektacytometry.
    Cummings DM; Ballas SK
    Angiology; 1990 Feb; 41(2):118-23. PubMed ID: 2306004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentoxifylline, diltiazem, and A23187: effects on deformability and volume of human red blood cells.
    Dodson RA; Hinds TR; Vincenzi FF
    Proc West Pharmacol Soc; 1988; 31():205-7. PubMed ID: 3145500
    [No Abstract]   [Full Text] [Related]  

  • 4. A new method of measuring red cell deformability and the effects of pentoxifylline.
    Isogai Y; Mochizuki K; Ashikaga M
    Curr Med Res Opin; 1981; 7(6):352-8. PubMed ID: 7238085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of pentoxifylline on filterability of normal red blood cells and their adhesiveness to cultured endothelial cells.
    Sowemimo-Coker SO; Turner P
    Eur J Clin Pharmacol; 1985; 29(1):55-9. PubMed ID: 2996906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythrocyte deformability in canine septic shock and the efficacy of pentoxifylline and a leukotriene antagonist.
    Puranapanda V; Hinshaw LB; O'Rear EA; Chang AC; Whitsett TL
    Proc Soc Exp Biol Med; 1987 Jun; 185(2):206-10. PubMed ID: 3554261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Erythrocyte deformability in progressive muscular dystrophy and effect of pentoxifylline].
    Chen SS; Liu JS
    Taiwan Yi Xue Hui Za Zhi; 1986 Mar; 85(3):249-57. PubMed ID: 3462309
    [No Abstract]   [Full Text] [Related]  

  • 8. Dose-response effects of pentoxifylline on erythrocyte filterability: clinical and animal model studies.
    Ambrus JL; Anain JM; Anain SM; Anain PM; Anain JM; Stadler S; Mitchell P; Brobst JA; Cobert BL; Savitsky JP
    Clin Pharmacol Ther; 1990 Jul; 48(1):50-6. PubMed ID: 2196145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of effect of pentoxifylline on red blood cell deformability.
    Cummings DM; Ballas SK; Ellison MJ
    J Clin Pharmacol; 1992 Nov; 32(11):1050-3. PubMed ID: 1474167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythrocyte deformability in a red cell ageing model.
    Leonhardt H; Grigoleit HG; Reinhardt I
    Ric Clin Lab; 1978; 8(1-2):65-71. PubMed ID: 705180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A controlled trial of pentoxifylline (Trental 400) in intermittent claudication: clinical, haemostatic and rheological effects.
    Reilly DT; Quinton DN; Barrie WW
    N Z Med J; 1987 Jul; 100(828):445-7. PubMed ID: 3330188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of pentoxifylline or cilostazol to improve blood and plasma viscosity, fibrinogen, and erythrocyte deformability in claudication.
    Dawson DL; Zheng Q; Worthy SA; Charles B; Bradley DV
    Angiology; 2002; 53(5):509-20. PubMed ID: 12365857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pentoxifylline in changes of the statoacoustic apparatus during vascular diseases. Its action on erythrocyte flexibility].
    Pallestrini E; Garaventa G; Cagetti P; Benedetti G; Valle MT; Accomando E; Castiglia G
    Clin Ter; 1986 Aug; 118(4):239-46. PubMed ID: 3489580
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative efficacy of vinpocetine, pentoxifylline and nicergoline on red blood cell deformability.
    Hayakawa M
    Arzneimittelforschung; 1992 Feb; 42(2):108-10. PubMed ID: 1610415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Filtrability investigations with red blood cell (RBC) suspensions: effects of different blood components and pentoxifylline on RBC flow rate.
    Seiffge D; Kiesewetter H
    Ric Clin Lab; 1981; 11 Suppl 1():117-23. PubMed ID: 7188104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical and hemorrheologic effects of pentoxifylline in patients with obliterative arteriopathy of the legs].
    Vaya A; Martínez M; Carbonell P; Aznar J
    Angiologia; 1987; 39(6):262-8. PubMed ID: 3425972
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hemolysis and red cell deformability during cardiopulmonary bypass--the effect of prostaglandin E1 for prevention of hemolysis].
    Yamaguchi H; Shimizu T; Akutsu H; Kawachi K; Osada K; Fujikawa T; Suesada H; Hirayama T; Ishimaru S; Furukawa K
    Nihon Kyobu Geka Gakkai Zasshi; 1990 Apr; 38(4):625-9. PubMed ID: 2373896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional vascular disorders: treatment with pentoxifylline.
    Neirotti M; Longo F; Molaschi M; Macchione C; Pernigotti L
    Angiology; 1987 Aug; 38(8):575-80. PubMed ID: 3631642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of pentoxifylline on the flow properties of human blood.
    Ehrly AM
    Curr Med Res Opin; 1978; 5(8):608-13. PubMed ID: 710175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of pentoxifylline on red blood cell deformability and blood viscosity under hyperosmolar conditions.
    Leonhardt H; Grigoleit HG
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Sep; 299(2):197-200. PubMed ID: 909613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.